Effect of alemtuzumab over sNfL and sGFAP levels in multiple sclerosis

MLA

Raquel Sainz-Amo, et al. “Effect of Alemtuzumab over SNfL and SGFAP Levels in Multiple Sclerosis.” Frontiers in Immunology, vol. 15, Aug. 2024. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1454474.

APA

Raquel Sainz-Amo, Alexander Rodero Romero, Enric Monreal, Juan Luis Chico García, José Ignacio Fernández Velasco, Noelia Villarrubia, Jose Luis Veiga González, Susana Sainz de la Maza, Fernando Rodríguez Jorge, Jaime Masjuan, Lucienne Costa-Frossard, & Luisa María Villar. (2024). Effect of alemtuzumab over sNfL and sGFAP levels in multiple sclerosis. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1454474

Chicago

Raquel Sainz-Amo, Alexander Rodero Romero, Enric Monreal, Juan Luis Chico García, José Ignacio Fernández Velasco, Noelia Villarrubia, Jose Luis Veiga González, et al. 2024. “Effect of Alemtuzumab over SNfL and SGFAP Levels in Multiple Sclerosis.” Frontiers in Immunology 15 (August). doi:10.3389/fimmu.2024.1454474.